Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis and an inducer of neural differentiation. We previously reported the loss of PEDF expression in glioma progression. In this study, we investigated whether PEDF overexpression could suppress glioma growth and invasion. Glioma cell line U251 was stably transfected with a full-length human PEDF expression vector. The expression and release of various cytokines and angiogenic factors into the medium were analyzed by realtime reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and gelatin zymography. Apoptosis was checked by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. Growth inhibition was evaluated by using the in vitro Matrigel invasion. Tumorigenicity was examined in vivo by subcutaneous xenotransplantation into severe combined immunodeficient mice. In U251 cells overexpressing PEDF, thrombospondin-1 protein was upregulated (5.3-fold more), but the production of vascular endothelial growth factor (VEGF) (1.8-fold less) and basic fibroblast growth factor (2.5-fold less) was lower than in cells transfected with the vector only. PEDF also downregulated the production of matrix metalloproteinase-9. Conditioned medium collected from the PEDF-transfected U251 cells showed a significant reduction of VEGF expression. In vitro invasiveness was reduced by approximately 40%. PEDF expression prevented the growth of transfected cells and caused a significant increase in the percentage of cells undergoing apoptosis (50.4% in PEDF-transfected cells). Furthermore, the size of xenotransplants was significantly smaller. In conclusion, PEDF overexpression decreased malignancy, and this might be attributed to the promotion of apoptosis and the regulation of expression of angiogenic effectors. Thus, treatment with PEDF may be useful in patients with malignant gliomas. However, the mechanism of apoptosis induction needs to be investigated.
P igment epithelium-derived factor (PEDF), a 50-kDa glycoprotein initially isolated from retinal pigment epithelial (RPE) cells, is recognized for its neurotrophic activity on cells derived from the neural crest. 1, 2 It shares high sequence homology with other serine proteinase inhibitors (serpins) and behaves like a noninhibitory serpin. 3 PEDF is found in a broad range of human fetal and adult tissues, including almost all brain areas. 4 Later studies have demonstrated that it can promote the survival of cerebellar granule cells (CGCs), 5 induce differentiation in retinoblastoma tumor cells in vitro, 6 and protect retinal neurons from apoptotic death. 7 Another property of PEDF is its antiangiogenic function. Biochemically purified and recombinant forms of PEDF potently inhibited neovascularization in rat corneas. PEDF inhibited endothelial cell migration in a dose-dependent manner, placing it among the most potent natural inhibitors of angiogenesis. 8 Additionally, PEDF also completely blocks rat microglial cell division induced by granulocyte-macrophage colony-stimulating factor. 9 Several clinical and laboratory studies have shown that the ''gliastatic'' effect of PEDF, along with the neuronsurvival character, could be of benefit in the management of some diseases related to the central nervous system. [10] [11] [12] However, little is known about the effect of PEDF on the growth and invasion of glioma, which constitutes the majority of primary brain tumors.
Our preliminary study showed that PEDF expression levels, in terms of both mRNA and protein, were significantly reduced in high-grade gliomas than that in low-grade ones, suggesting that PEDF expression may suppress the growth of this often highly aggressive tumor. 13 The present study was designed to determine whether the reactivation of PEDF gene expression leads to inhibition of cancer development in terms of invasiveness, in vivo tumor growth, and angiogenesis. Expressions of angiogenesis-related genes such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), thrombospondin-1 (TSP-1), and matrix metalloproteinase (MMP) were analyzed as indicators of cell invasiveness and metastatic potential. The effect of PEDF on cell migration was measured using an in vitro invasion assay with a Boyden chamber. The apoptosis ability of PEDF-transfected cells exposed to H 2 O 2 was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). Finally, the effects of PEDF on tumor growth in vivo were investigated in severe combined immunodeficient (SCID) mice.
Materials and methods

Cell culture
Human malignant U251 glioma cells were obtained from American Type Culture Collection (Manassas, VA). As shown in the manufacturer's instructions, U251 cells were derived from surgical specimen taken from a 75-year-old male with malignant glioblastoma and the cells were positive for glial fibrillary acidic protein (GFAP). They were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum, 2 mM l-glutamine, 100 IU/ ml penicillin G, and 100 mg/ml streptomycin at 371C in a humidified 5% CO 2 atmosphere.
Stable transfection of PEDF cDNA
A PEDF cDNA expression vector was constructed by ligating the full-length human PEDF cDNA (1254 bp) into the HindIII-XbaI restriction enzyme sites of pcDNA3 mammalian expression vector (Invitrogen, Shanghai, China). Restriction enzyme mapping and DNA nucleotide sequencing performed on the plasmid from transformed clones confirmed the cloning of PEDF in the right orientation. A total of 10 mg of PEDF cDNA plasmid constructs were transfected into U251 cells cultivated in 100-mm tissue culture dishes by means of Lipofectamine (Invitrogen) in RPMI-1640 containing Geneticin (400 mg/ml). U251 cells transfected with pcDNA3 empty vector plasmid DNA were used as the control. The expression of PEDF mRNA in stably transfected clones were screened by reverse transcription-polymerase chain reaction (RT-PCR), whereas PEDF protein was examined by Western blot analysis. After checking the efficiency of the transfection, a clone with vector alone (U251 CON ) and a clone overexpressing PEDF (U251 PEDF ) were selected for further experiments.
Real-time RT-PCR
Total RNA from U251 PEDF and U251 CON cells was extracted, respectively, treated with DNase, and subjected to reverse transcription by following standard procedures. PCR amplifications were carried out with the Lightcycler instrument (Roche Molecular Biochemicals). Aliquots of cDNA (0.1 mg) and known amounts of external standards (purified PCR products diluted in RT mix, 10 2 -10 9 molecules) were amplified in parallel reactions (final volume 20 ml), using the FastStart SYBR Green master mix (Roche Molecular Biochemicals). The optimal cycle programs were determined for each single gene in preliminary PCR runs to obtain a single, specific PCR product, which was verified by DNA sequencing. Quantification was performed by real-time detection of fluorimetric emission of SYBR green I measured at the end of each elongation phase (corresponding to the amount of PCR product), and by comparison of the fluorescence of PCR products of unknown concentration with the fluorescence of the external standards. Only fluorescence values measured in the log-linear phase of amplification were considered, with the use of the second derivative maximum method of the Lightcycler data analysis software. For each single determination, the PCRs were run in quadruplicate and gave an average variability of less than 10%. Primers and annealing temperatures are listed in Table 1 . The use of a reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) allows us to normalize the differences in the amount of total RNA added to a reaction and to compensate for different RT efficiencies. All PCR efficiencies were 40.91.
Application of conditioned medium to the wild-type cells U251 PEDF and U251 CON cells were maintained at a density of 10 5 cells/ml in growth medium supplemented with 1% FBS. After confluence, the culture medium was harvested and centrifuged for 10 minutes at 2000 g to remove any particulates and cell debris. Thereafter, the medium was 0.2 mm-filtration sterilized (Gelman Sciences, Western blot analysis and ELISA U251 PEDF and U251 CON cells were washed three times with ice-cold phosphate-buffered saline (PBS), harvested by scraping, and homogenized in an appropriate amount of the homogenizing buffer (20 mM HEPES buffer containing 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol (DTT), 0.1 mM leupeptin, 75 mM pepstatin A, 150 mM NaCl, and 0.1% Triton X-100). The homogenates were centrifuged at 15,000 g for 15 minutes at 41C, and the supernatants were collected. After determination of the protein concentration using the Bio-Rad protein assay, an equal amount of protein (50 mg) from each sample was subjected to 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and electrophoretically transferred to a nitrocellulose membrane. After it was blocked with 5% skimmed milk in PBS with 0.1% Tween 20 for 1 h at room temperature, the membrane was incubated with the different primary antibodies: anti-human PEDF (Chemicon, Temecula, CA; 2 mg/ml), anti-human VEGF (R&D Systems, Minneapolis, MN 2 mg/ml), anti-human p53 (Oncogene, Cambridge, MA; 10 mg/ml), and anti-human caspase-3 (Oncogene, 1 mg/ml). After incubation with the secondary antibody, rabbit antimouse IgG absorbed horseradish peroxidase conjugate (Dako, Cambridge, UK, 1:1000), for 1 h at room temperature, the immunoreactive bands were detected using an enhanced chemiluminescence Western blotting analysis system (Amersham, Bucks, UK). The expressions of bFGF, VEGF, and TSP-1 in cell lysates were determined by ELISA kits (R&D Systems and Chemicon, respectively).
Gelatin zymography
A total of 1 Â 10 6 U251 PEDF and U251 CON cells were grown overnight in serum-free RPMI-1640, respectively. Culture media were collected and analyzed with 10% SDS-PAGE containing 1 mg/ml gelatin. Samples were applied to the gel in a sample buffer containing 2.5% SDS but lacking b-mercaptoethanol. After electrophoresis, the gels were incubated overnight at 371C in 50 mmol/l TrisHCl (pH 7.4), 10 mmol/l CaCl 2 , and 0.05% Triton-100 solution. Subsequently, the gels were stained with Coomassie brilliant blue R-250. The gelatinase activities were expressed as relative density when compared to control.
Cell viability assay
U251 PEDF and U251 CON cells (10 3 cells) were seeded in a 96-well plate and the cells were growth-arrested at G0 phase by incubating in serum-free medium for 24 hours. Then, the cells were changed to medium containing 1% FBS. After 4 days, 5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, St Louis, MO) was added for 4 hours. The crystal was dissolved in 0.04 M HCl in isopropanol and the absorbance at 570 nm was taken by a microplate reader (BioRad, Hercules, CA).
Cell invasion assay
ECMatrix (Chemicon) was rehydrated with serum-free medium and U251 PEDF and U251 CON cells (5 Â 10 4 cells) were resuspended in 300 ml of volume and seeded on the upper part of each chamber, respectively. After incubation for 16 hours at 371C, nonmigratory cells on the upper surface of the polycarbonate membrane and migrated cells on the lower surface of the membrane were counted, and the extent of migration was expressed as an average number of cells per microscopic field taken at Â 400 magnification.
Apoptosis assay
U251 PEDF and U251 CON cells were plated on glass coverslips, respectively, and exposed to 10, 50, or 100 mM H 2 O 2 , and fixed with 4% paraformaldehyde in PBS for 20 minutes. Cells were washed in PBS and treated with 0.3% H 2 O 2 for 30 minutes to eliminate endogenous peroxidases and then incubated in 50 mM Tris-HCl buffer (pH 7.5). Apoptosis was carried out by in situ TUNEL analysis. Apoptosis was quantified by determining the percentage of positively stained cells in all of the nuclei in 10 randomly chosen fields/section taken at Â 400 magnification.
Tumor growth of PEDF-transfected U251 cells in SCID mice
Female SCID mice 6-7 weeks of age were divided into two groups with five mice in each group. U251 PEDF and U251 CON cells were suspended in 0.1 ml of PBS and inoculated into both flanks using 23-gauge needles. Mice were observed on a twice-weekly basis to check for tumor growth. Tumors were measured in three dimensions with calipers, and tumor volume was calculated assuming that the tumors were ellipsoid. The mice were euthanized after 6 weeks, and the tumors were excised and weighed. Tumor volumes were estimated by multiplying length Â width Â height Â 0.5.
Results
Cloning and expression of PEDF in U251 cells
After transfection of U251 cells with the PEDF construct DNA and subsequent neomycin G418 antibiotic selection, 10 individual clones were isolated and grown in 24-well culture plates. The expression of PEDF in stably transfected U251 was confirmed by Western blot analysis. Overexpression of PEDF was detected in the U251 PEDF but was very low in the control cells (U251 CON ) (Fig 1) . ELISA and real-time RT-PCR were used to evaluate whether the overexpression of PEDF would affect the production of positive and negative effectors of angiogenesis. The level of angiogenic factors, namely VEGF, bFGF, and TSP-1 were measured by ELISA in cell lysates from U251 PEDF and U251 CON cells ( Table 2 ). The concentration of each factor was normalized against the total protein, which was measured using a DC protein assay kit (Bio-Rad). U251 PEDF cells showed a dramatic increase (up to 5.3-fold) of TSP-1 production (Po.001) when compared with U251 CON cells. Also, U251 PEDF cells released reduced VEGF (1.8-fold less) (P ¼ .023) and bFGF (2.5-fold less) (P ¼ .009) than U251 CON cells. To investigate whether the changes in the production of the effectors of angiogenesis in cell lysates were corrected with the respective mRNA levels, we employed a quantitative, external standard-based, real-time PCR approach. Both VEGF and bFGF expression were downregulated, after normalization with the housekeeping GAPDH mRNA in U251 PEDF cells, and TSP-1 expression was shown to be increased (Fig 2) .
Gelatin zymography
To examine the effect of PEDF expression on MMP-2 and MMP-9 activities, we prepared culture media from 
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U251 PEDF and U251 CON cells and performed gelatin zymography. In both culture media of U251 PEDF and U251 CON cells, latent MMP-2 (72 kDa in molecular mass) was detected. The difference of MMP-2 expression levels between both cell types was not significant. The activity of the latent form of MMP-9 (separating at 92 kDa in molecular mass) in U251 PEDF culture media was 2.5-fold less than that from the control cells (Fig 3) .
Effect of conditioned medium by transfected U251 cells on VEGF expression of wild-type U251 cells
Conditioned medium obtained from U251 PEDF cells strongly suppressed VEGF expression as compared with U251 CON (Fig 4) . This response was identical to the result observed in the lysates of U251 PEDF cells.
Cell viability and apoptosis analysis
In order to examine whether PEDF overexpression affected U251 cell viability, MTT assay was performed. (Fig 6) .
Invasiveness of PEDF-transfected U251 cells
Since PEDF affected MMP-9 expression, we further investigated whether PEDF expression influenced the invasive capacity of the glioma cells. The percentage of stained cells on the lower surface of the Matrigel membrane was found to be higher for U251 CON clone (1.7-fold more) than that of U251 PEDF (Fig 7) . Therefore, PEDF expression decreased the matrix protein-mediated mobility of U251 cells.
SCID mice tumorigenicity assay
To determine whether PEDF overexpression affected tumorigenicity in vivo, xenografting was conducted for U251 PEDF 
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Discussion
Previous work has proven that PEDF exists in almost all regions in the adult brain, 4 indicating that it could be of particular importance as an autocrine/paracrine factor. We recently found that glioblastomas produce significantly lower levels of PEDF than other lower-grade tumors and normal brain tissues. 13 Our study demonstrated for the first time that PEDF is involved in the regulation of tumor angiogenesis and invasiveness in vivo and in vitro, by downregulating VEGF and bFGF, and potentiating the cell to apoptotic inducers.
Malignant gliomas are highly vascularized. Previous clinical studies showed that they had a high incidence of recurrence with poor prognosis.
14 It has been hypothesized that the development of malignant gliomas depends on the presence of and the balance between stimulatory and inhibitory factors of angiogenesis. In our work, we found that PEDF expression decreased the production of angiogenic stimulators (VEGF and bFGF) and enhanced the production of angiogenic inhibitor (TSP-1). This might help to retard the progression of glioma cells by influencing the levels of different angiogenic regulators Figure 6 Western blot analysis of apoptosis-related protein p53 (a) and caspase-3 (b) expression of U251 PEDF and U251 CON exposed to 100 mM H 2 O 2 . The protein bands in the photograph were scanned and analyzed using a laser densitometer linked to a computer analysis system. p53 and caspase-3 band density were normalized by b-actin and expressed as values relative to the control. U251 PEDF expressed a higher level of p53 (5.8-fold) and caspase-3 (2.7-fold) than did the control cells (*Po.05, Mann-Whitney's t-test).
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towards the direction of inhibition of neovascularization. This supposition is supported by previous studies of ocular diseases. 15, 16 Also, Mori et al 17 demonstrated that PEDF gene transfer could be a promising approach for the treatment of retinal and choroidal neovascularization. In our study, the increase of production of antiangiogenic TSP-1 in U251 PEDF cells was particularly significant (5.3-fold more) when compared to the reduced expression of proangiogenic VEGF (1.8-fold less) and bFGF (2.5-fold less). Together with the reduced resistance to apoptotic induction in U251 PEDF cells, this suggests that PEDF can halt or slow down the rate of angiogenesis, which has been shown to be an alternative for the treatment of gliomas. [18] [19] [20] Local invasiveness is an important characteristic of gliomas and it contributes substantially to the failure of curative treatments of the disease. To invade into and propagate in the normal tissue, tumor cells need efficient degradation of various components of extracellular matrix (ECM), in particular fibronectin, laminin, and type IV collagen. 21 Of the several known families of ECM-degrading enzymes, the most extensively studied is MMPs. It had shown that expression of MMP-9 (type IV collagenase of 92 kDa in molecular mass) in glial tumor cells correlated with its malignancy. 22 In our study, U251 PEDF cells showed reduced MMP-9 gelatinase activity than the control cells. Concomitantly, the cells exhibited decreased invasiveness, as determined by the ECMatrix study. This indicates that the reduced invasiveness may relate with reduced MMP-9 activity, as an effect of PEDF expression.
Gliomas, especially glioblastoma multiform, are usually radio-and chemo-resistant. The tumor cells propagate rapidly in brain tissue, often rendering difficulty in antitumor treatments as well as complete surgical resection. 23 It was shown that the resistance to anticancer treatment was partially due to a dysfunction of an apoptotic program in the tumors. 24 In our work, PEDF expression elicited a significant increase of apoptosis to the treatment with 100 mM H 2 O 2 , although no significant change in apoptosis was observed with low doses of H 2 O 2 . Apoptosis is a tightly regulated process involving several signaling pathways, such as the well-known families of caspases and p53. Our Western blot analysis showed that p53 and caspase-3 were upregulated after 100 mM H 2 O 2 treatment of U251 PEDF cells. They exhibited less resistance to chemical-induced apoptosis than U251 CON cells. This suggested that the expression of PEDF in glioma might render the tumor cells to be more susceptible to apoptotic induction, which is a common therapeutic module for cancer treatment.
Our result provided another face of mirror for the effect of PEDF on cell apoptosis. Taniwaki et al 5 found that PEDF did not induce a neuronal phenotype in CGCs but markedly enhanced CGC survival, suggesting that PEDF could be a potent inhibitor of natural and induced apoptosis. Araki et al 25 found that the death of CGCs occurred mostly by ''natural apoptosis'' but not by PEDF induction. Nevertheless, Bilek et al 10 showed that PEDF was effective in protecting the neurons against neurotoxins, such as glutamate. 26 From these studies, it raises controversy as to the action of PEDF in antiapoptosis of CGCs and neurons and proapoptosis in glioma cells. This is not the first time that this factor can exert dual or opposite effects on different cell types. PEDF has been found to have opposite effects on the proliferation of endothelial cells showing different phenotypes. 27 A possible explanation is that PEDF may bind to more than one type of receptor on the cell surface and this elicits different cascades of signal transduction resulting in opposite effects. The exact mechanism of the PEDF induction needs to be further investigated.
The multiple antitumor activities effected by PEDF, together with the neuroprotective characteristics, indicate that PEDF could provide an efficient blockade to glioma cell growth, as proven by Crawford et al 12 in the study of neuroblastoma. This explains as to why neuroblastoma with a vast population of PEDF-producing Schwann cells is usually more benign and suggests that endogenous PEDF expression can contribute to tumor regression. In addition, exogenous PEDF can be envisaged as a sole treatment agent or as an adjunct to chemotherapeutic modalities to stabilize or suppress the glioma development and metastasis.
In conclusion, our study demonstrated the suppression of VEGF and bFGF as well as induction of TSP-1 by PEDF expression in glioma cells. Also, PEDF reduced the tumor cell invasiveness by regulating the MMP-9 expression and promoting the sensitivity of cells to apoptotic induction. This resulted in significant retardation of tumor progression in immunodeficient mice. Our findings suggest that PEDF activation can be an effective treatment for glioma. /insert on 8-mm pore membranes in Transwell chambers, respectively. After incubation for 16 hours in a CO 2 incubator, the number of the penetrated single tumor cells was counted under a phase-contrast microscope. Results are given as relative value relative to U251 CON (mean7SE; n ¼ 4) (*Po.05, Mann-Whitney's t-test).
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